Evotec SE reports Q1 results
Source: SeekingAlpha
2025-05-06 08:32:24 ET
More on Evotec SE
- Evotec SE (EVO) Q4 2024 Earnings Call Transcript
- Evotec SE 2024 Q4 - Results - Earnings Call Presentation
- Evotec SE reports Q4 results; initiates outlook for FY25 and FY28
- Seeking Alpha’s Quant Rating on Evotec SE
- Historical earnings data for Evotec SE
Read the full article on Seeking Alpha
For further details see:
Evotec SE reports Q1 results
Evotec SE
NASDAQ: EVO
EVO Trading
-0.6% G/L:
$2.465 Last:
58,894 Volume:
$2.47 Open:
EVO Latest News
March 19, 2026 02:50:00 am
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
January 08, 2026 01:50:00 am
Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access
January 02, 2026 12:30:00 am
Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations
December 08, 2025 01:20:00 am
Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz
EVO Stock Data
$320,181,806
73,171,742
N/A
9
N/A
Biotechnology & Life Sciences
Healthcare
DE
Hamburg
